2026-01-22 - Analysis Report
**Thermo Fisher Company Overview**
Thermo Fisher Scientific is a multinational biotechnology and life sciences company that develops and manufactures pharmaceutical, diagnostic, research, and industrial products.

**Return Rate Comparison**
Cumulative return of review stock (TMO): **45.39%**
Cumulative return of comparison stock (S&P 500, VOO): **91.55%**
Divergence from S&P 500: **-51.90**, Relative divergence: **14.30%** (indicating the review stock's current position in the divergence range)

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 21.0% | 17.1% | 16.0% | 1.1 | 84.1B |
| 2017-2019  | 46.0% | 17.1% | 29.0% | 1.1 | 122.1B |
| 2018-2020  | 22.0% | 17.1% | 1.0% | 0.8 | 175.0B |
| 2019-2021  | 77.0% | 15.0% | 34.0% | 0.8 | 250.7B |
| 2020-2022  | 8.0% | 25.4% | 10.0% | 0.8 | 206.9B |
| 2021-2023  | -30.0% | 28.6% | -31.0% | 0.9 | 199.4B |
| 2022-2024  | -37.0% | 24.4% | -57.0% | 0.9 | 195.4B |
| 2023-2025  | -17.0% | 27.2% | -79.0% | 0.8 | 217.7B |
**Analysis:** Thermo Fisher's return on investment varied significantly over the years, with some periods witnessing growth rates as high as 77%.

**Recent Stock Price Fluctuations**
| Metric              | Value          |
|---------------------|----------------|
| Close               | $636.30       |
| Last-market Change  | 2.79%         |
| 5-day SMA           | $624.10       |
| 20-day SMA          | $603.67       |
| 60-day SMA          | $583.82       |
**Analysis:** Currently, the stock is moving higher with a relatively steady trend, as supported by its moving averages.

**RSI, PPO Index Indicators**
| Indicator          | Value                     |
|---------------------|----------------------------|
| RSI                 | 71.19                     |
| PPO                 | 0.30                      |
| Hybrid Signal       | Buy                       |
| Risk Level          | Medium                    |
| Recent relative     | 0.60 (+): improving     |
| Divergence change    | (+): improving           |
| 7-day Rank change    | (+) 31: rank up          |
| 7-day Dynamic       | -2.90 (-): worsening     |
**Analysis:** The RSI is elevated, the PPO is low, and the relative divergence change indicates improvement.

**Expected Return**
**Expected Return:** **-43.90%** (compared to the S&P 500 if invested long-term from this point)
**Analysis:** The expected return indicates a potential loss if invested long-term, which should be taken into account when making investment decisions.

**Recent News & Significant Events**

[2026-01-21] P/E Ratio Insights for Thermo Fisher Scientific - Benzinga (link)
[2026-01-06] Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance (link)
[2026-01-06] Here's How Much You'd Have If You Invested $1000 in Thermo Fisher Scientific a Decade Ago - Nasdaq (link)
[2026-01-21] Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings - TechStockÂ² (link)
[2026-01-15] Thermo Fisher Scientific Inc. $TMO Stock Position Raised by MGO One Seven LLC - MarketBeat (link)
[2026-01-19] Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory - Insider Monkey (link)
**Analysis:** There are various articles and news pieces highlighting the performance of Thermo Fisher's stock and its overall market situation.

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.54 (~Buy)
- Opinions: 23
- Target Price (avg/high/low): 652.61 / 750.00 / 575.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|-:|
| 2025-10-31 | 4.28 | 11.12 B$ |
| 2025-08-01 | 4.28 | 10.86 B$ |
| 2025-05-02 | 3.99 | 10.36 B$ |
| 2024-11-01 | 4.26 | 10.60 B$ |
| 2025-10-31 | 4.26 | 10.60 B$ |
**Analysis:** Thermo Fisher's earnings have been increasing over the years, indicating overall growth.

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $11.12B | 41.21% |
| 2025-06-30 | $10.85B | 40.61% |
| 2025-03-31 | $10.36B | 40.86% |
| 2024-12-31 | $11.39B | 42.32% |
| 2024-09-30 | $10.60B | 40.84% |
**Analysis:** Revenue has steadily increased with relatively stable profit margins.

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $51.02B | 3.17% |
| 2025-06-30 | $50.51B | 3.20% |
| 2025-03-31 | $49.39B | 3.05% |
| 2024-12-31 | $49.59B | 3.69% |
| 2024-09-30 | $48.99B | 3.33% |
**Analysis:** Equity has steadily increased with relatively stable ROE.

**Comprehensive Analysis (Summary of previous items)**
Thermo Fisher's return on investment varied, stock price moved higher with a relatively steady trend, RSI is high, expected return is negative, recent news indicate growth, analysts are positive, earnings and revenue have grown steadily, and capital and profitability remain stable.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.